Early diagnosis of Parkinson's disease (PD) is of primary importance. The delayed (3-4 h after injection) Iodine-123-Metaiodobenzylguanidine (123I-mIBG) scintigraphy has been proven to be effective in early differential diagnosis for Lewy body disease. But early imaging (15-30 min after injection) has only been marginally studied for its possible diagnostic role. In this prospective study, a threshold for the early Heart-to-Mediastinum (H/M) count ratio has been investigated, obtaining a diagnostic accuracy analogous to conventional, delayed imaging
Copyright: © 2014 Miyazaki Y, et al. This is an open-access article distributed under the terms of ...
Dopamine transporter scans of some patients who have been clinically diagnosed with Parkinson's ...
The purpose of this study was to investigate myocardial uptake of 123I-metaiodobenzylguanidine (MIBG...
Early diagnosis of Parkinson's disease (PD) is of primary importance. The delayed (3-4 h after injec...
Background: Early diagnosis of Parkinson's disease (PD) is of primary importance. The delayed (3-4 h...
Early diagnosis of Parkinson's disease (PD) is of primary importance. The delayed (3-4 h after injec...
The use of 123I-mIBG has been approved for decades for Parkinson's disease (PD) diagnosis and as a p...
The use of 123 I-mIBG has been approved for decades for Parkinson's disease (PD) diagnosis and as a ...
International audienceBACKGROUND: Different studies have found diminished cardiac metaiodobenzylguan...
Objective(s): Iodine-123 metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy has been used t...
Background 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy is a useful tool for differe...
Background 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy is a useful tool for differe...
Purpose: To provide reliable and reproducible heart/mediastinum (H/M) ratio cut-off values for parki...
In some cases, it is difficult to differentiate essential tremor (ET) from Parkinson's disease (PD),...
Dopamine transporter scans of some patients who have been clinically diagnosed with Parkinson's ...
Copyright: © 2014 Miyazaki Y, et al. This is an open-access article distributed under the terms of ...
Dopamine transporter scans of some patients who have been clinically diagnosed with Parkinson's ...
The purpose of this study was to investigate myocardial uptake of 123I-metaiodobenzylguanidine (MIBG...
Early diagnosis of Parkinson's disease (PD) is of primary importance. The delayed (3-4 h after injec...
Background: Early diagnosis of Parkinson's disease (PD) is of primary importance. The delayed (3-4 h...
Early diagnosis of Parkinson's disease (PD) is of primary importance. The delayed (3-4 h after injec...
The use of 123I-mIBG has been approved for decades for Parkinson's disease (PD) diagnosis and as a p...
The use of 123 I-mIBG has been approved for decades for Parkinson's disease (PD) diagnosis and as a ...
International audienceBACKGROUND: Different studies have found diminished cardiac metaiodobenzylguan...
Objective(s): Iodine-123 metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy has been used t...
Background 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy is a useful tool for differe...
Background 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy is a useful tool for differe...
Purpose: To provide reliable and reproducible heart/mediastinum (H/M) ratio cut-off values for parki...
In some cases, it is difficult to differentiate essential tremor (ET) from Parkinson's disease (PD),...
Dopamine transporter scans of some patients who have been clinically diagnosed with Parkinson's ...
Copyright: © 2014 Miyazaki Y, et al. This is an open-access article distributed under the terms of ...
Dopamine transporter scans of some patients who have been clinically diagnosed with Parkinson's ...
The purpose of this study was to investigate myocardial uptake of 123I-metaiodobenzylguanidine (MIBG...